AC Immune S.A.

ACIU · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$16-$21-$19-$16
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$2$1
Change in WC-$0$2-$2$22
Other Non-Cash-$3$2$0-$2
Operating Cash Flow-$18-$16-$19$6
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$21$24$3-$4
Investing Cash Flow$21$24$3-$4
Financing Activities
Debt Repay.-$0-$0-$0-$0
Stock Issued$0$0$0-$0
Stock Repurch.$0$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0-$0
Financing Cash Flow-$0-$0-$0-$0
Forex Effect-$0-$2-$0$2
Net Chg. in Cash$2$6-$16$4
Supplemental Information
Beg. Cash$26$20$36$32
End Cash$28$26$20$36
Free Cash Flow-$18-$16-$19$6
AC Immune S.A. (ACIU) Financial Statements & Key Stats | AlphaPilot